Medite Cancer Diagnostics Inc (MDIT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Medite Cancer Diagnostics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2018 | 0.94 |
June 30, 2018 | 0.9453 |
March 31, 2018 | 0.9351 |
December 31, 2017 | 0.916 |
September 30, 2017 | 0.6248 |
June 30, 2017 | 0.3911 |
March 31, 2017 | 0.4307 |
December 31, 2016 | 0.5098 |
September 30, 2016 | 0.4921 |
June 30, 2016 | 0.4932 |
March 31, 2016 | 0.4579 |
December 31, 2015 | 0.426 |
September 30, 2015 | 0.2776 |
June 30, 2015 | 0.2922 |
March 31, 2015 | 0.4132 |
December 31, 2014 | 0.4464 |
September 30, 2014 | 0.3102 |
June 30, 2014 | 0.3192 |
March 31, 2014 | -0.008 |
December 31, 2013 | 1.642 |
September 30, 2013 | -0.0093 |
June 30, 2013 | -0.0095 |
March 31, 2013 | -0.0096 |
December 31, 2012 | -0.0096 |
September 30, 2012 | -0.0102 |
Date | Value |
---|---|
June 30, 2012 | -0.0101 |
March 31, 2012 | -0.0106 |
December 31, 2011 | -0.0113 |
September 30, 2011 | -0.0169 |
June 30, 2011 | -0.02 |
March 31, 2011 | -0.0326 |
December 31, 2010 | -0.0468 |
September 30, 2010 | -0.064 |
June 30, 2010 | -0.0438 |
March 31, 2010 | -0.0387 |
December 31, 2009 | -0.0331 |
September 30, 2009 | -0.0318 |
June 30, 2009 | -0.0441 |
March 31, 2009 | -0.0469 |
December 31, 2008 | 0.1759 |
September 30, 2008 | 0.0438 |
June 30, 2008 | 0.0239 |
March 31, 2008 | 0.0154 |
December 31, 2007 | -0.0216 |
September 30, 2007 | -0.0735 |
June 30, 2007 | 0.1354 |
March 31, 2007 | -1.838 |
December 31, 2006 | -0.2905 |
September 30, 2006 | -0.3883 |
June 30, 2006 | -0.4343 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 17.65M |
Total Liabilities (Quarterly) | 11.21M |
Shareholders Equity (Quarterly) | 6.438M |